000			01394 a2200385 4500
005			20250512113845.0
264		0	_c19730402
008			197304s 0 0 eng d
022			_a0032-5473
024	7		_a10.1136/pgmj.48.565.653 _2doi
040			_aNLM _beng _cNLM
100	1		_aRao, S K
245	0	0	_aAugmenting the action of levodopa. _h[electronic resource]
260			_bPostgraduate medical journal _cNov 1972
300			_a653-6 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAmantadine _xtherapeutic use
650	0	4	_aAntacids _xtherapeutic use
650	0	4	_aApomorphine _xadverse effects
650	0	4	_aCarboxy-Lyases _xantagonists & inhibitors
650	0	4	_aCatechol O-Methyltransferase Inhibitors
650	0	4	_aDihydroxyphenylalanine _xadministration & dosage
650	0	4	_aDopamine beta-Hydroxylase _xantagonists & inhibitors
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aMethyldopa _xtherapeutic use
650	0	4	_aMonoamine Oxidase Inhibitors _xtherapeutic use
650	0	4	_aParasympatholytics _xtherapeutic use
650	0	4	_aParkinson Disease _xdrug therapy
700	1		_aVakil, S D
700	1		_aCalne, D B
700	1		_aHilson, A
773	0		_tPostgraduate medical journal _gvol. 48 _gno. 565 _gp. 653-6
856	4	0	_uhttps://doi.org/10.1136/pgmj.48.565.653 _zAvailable from publisher's website
999			_c4572440 _d4572440